GoAI
Get started
Mental Health Technologies Co.,Ltd. logo

Mental Health Technologies Co.,Ltd.

9218.T

JPXHealthcareMedical - Healthcare Information Services

Open in GoAI

Latest quote

¥767

−¥5.00 · -0.65%

Aug 24, 3:30 PM JST

9218.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Operating in Japan, Mental Health Technologies Co.,Ltd. offers a diverse portfolio of services, encompassing mental wellness solutions, career development assistance for medical professionals, and digital advertising. The company additionally manages a cloud-based platform for industrial healthcare practitioners. Established in 2011, its corporate headquarters are located in Tokyo, Japan.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
JP
CEO
Shinnosuke Tone
Listed since
Mar 28, 2022
Employees
140

Market position

Day range

Current ¥767

52-week range

Current ¥767

Open
¥775
Previous close
¥772
Volume
27.7K
1.42× average
Average volume
19.46K
Average daily volume
Market cap
8.06B JPY
Beta
0.55
Market reference 1
50-day average
¥731.5
+4.85% above average
200-day average
¥764.93
+0.27% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
9.64B JPY
P/E (TTM)
33.91×
P/B (TTM)
5.01×
P/S (TTM)
1.07×
EV / EBITDA
14.56×
Earnings yield
2.99%
Free cash flow yield
6.56%
Dividend yield
1.30%

Profitability & efficiency

Gross margin
30.41%
Operating margin
8.18%
Net margin
3.15%
Return on equity
16.27%
Return on assets
4.75%
Return on invested capital
6.58%

Financial health

Debt / equity
1.82×
Current ratio
1.6×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends68%43%18%-7%Gross margin, FY2021: 51.31%Gross margin, FY2022: 61.31%Gross margin, FY2023: 54.25%Gross margin, FY2024: 34.33%Gross margin, FY2025: 31.57%Operating margin, FY2021: 9.57%Operating margin, FY2022: 16.17%Operating margin, FY2023: 19.21%Operating margin, FY2024: 2.14%Operating margin, FY2025: 7.45%Net margin, FY2021: 11.13%Net margin, FY2022: 11.59%Net margin, FY2023: 16.92%Net margin, FY2024: -0.58%Net margin, FY2025: 3.96%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 51.31%. Gross margin FY2022 61.31%. Gross margin FY2023 54.25%. Gross margin FY2024 34.33%. Gross margin FY2025 31.57%. Operating margin FY2021 9.57%. Operating margin FY2022 16.17%. Operating margin FY2023 19.21%. Operating margin FY2024 2.14%. Operating margin FY2025 7.45%. Net margin FY2021 11.13%. Net margin FY2022 11.59%. Net margin FY2023 16.92%. Net margin FY2024 -0.58%. Net margin FY2025 3.96%.

Income trends

Revenue

6.44B JPY+25.33%

Operating income

479.69M JPY+337.09%

Net income

254.9M JPY+284.68M JPY
Income trends across reported periods7.08B JPY4.5B JPY1.91B JPY−676.29M JPYRevenue, FY2021: 1.45B JPYRevenue, FY2022: 2.29B JPYRevenue, FY2023: 2.61B JPYRevenue, FY2024: 5.13B JPYRevenue, FY2025: 6.44B JPYOperating income, FY2021: 139.13M JPYOperating income, FY2022: 369.92M JPYOperating income, FY2023: 501.09M JPYOperating income, FY2024: 109.75M JPYOperating income, FY2025: 479.69M JPYNet income, FY2021: 161.83M JPYNet income, FY2022: 265.12M JPYNet income, FY2023: 441.37M JPYNet income, FY2024: −29.78M JPYNet income, FY2025: 254.9M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.45B JPY. Revenue FY2022 2.29B JPY. Revenue FY2023 2.61B JPY. Revenue FY2024 5.13B JPY. Revenue FY2025 6.44B JPY. Operating income FY2021 139.13M JPY. Operating income FY2022 369.92M JPY. Operating income FY2023 501.09M JPY. Operating income FY2024 109.75M JPY. Operating income FY2025 479.69M JPY. Net income FY2021 161.83M JPY. Net income FY2022 265.12M JPY. Net income FY2023 441.37M JPY. Net income FY2024 −29.78M JPY. Net income FY2025 254.9M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue6.44B JPY5.13B JPY2.61B JPY2.29B JPY1.45B JPY
Cost of goods sold4.4B JPY3.37B JPY1.19B JPY885.22M JPY707.71M JPY
Gross profit2.03B JPY1.76B JPY1.42B JPY1.4B JPY745.8M JPY
Selling, general, and administrative1.43B JPY1.65B JPY914.2M JPY1.03B JPY607.52M JPY
Operating expenses1.55B JPY1.65B JPY914.2M JPY1.03B JPY606.67M JPY
Interest income3.88M JPY119K JPY7K JPY39K JPY2K JPY
Interest expense41.88M JPY31.37M JPY3.24M JPY2.52M JPY2.15M JPY
Depreciation and amortization182.25M JPY147.84M JPY33.83M JPY26.96M JPY23.92M JPY
Operating income479.69M JPY109.75M JPY501.09M JPY369.92M JPY139.13M JPY
Net income254.9M JPY−29.78M JPY441.37M JPY265.12M JPY161.83M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
8.04

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates14.099.534.970.41Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 3.92, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 13.08, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 6.77, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual 8.3, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 9.01, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 0.48, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 5.21, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 8.04, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.52B2.13B1.74B1.36BQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 14, 2025: actual 1.46B JPY, estimate 1.53B JPY, surprise -4.58%, Miss. Q2 2025, reported May 15, 2025: actual 1.45B JPY, estimate 1.53B JPY, surprise -5.10%, Miss. Q3 2025, reported Aug 14, 2025: actual 1.57B JPY, estimate 1.68B JPY, surprise -6.43%, Miss. Q4 2025, reported Nov 14, 2025: actual 1.65B JPY, estimate 1.68B JPY, surprise -1.37%, Miss. Q1 2026, reported Feb 13, 2026: actual 1.76B JPY, estimate 1.77B JPY, surprise -0.90%, Miss. Q2 2026, reported May 15, 2026: actual 1.75B JPY, estimate 1.72B JPY, surprise +1.57%, Beat. Q3 2026, reported Aug 14, 2026: actual 2.35B JPY, estimate 2.27B JPY, surprise +3.34%, Beat. Q4 2026, reported Nov 18, 2026: actual —, estimate 2.42B JPY, surprise —, Comparison unavailable.

9218.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 9218.T

research.disclaimer